| Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2007 update of an American Society of Clinical Oncology practice guideline DA Loblaw, KS Virgo, R Nam, MR Somerfield, E Ben-Josef, ... Journal of Clinical Oncology 25 (12), 1596-1605, 2007 | 741 | 2007 |
| NCCN clinical practice guidelines in oncology: hepatobiliary cancers. AB Benson 3rd, TA Abrams, E Ben-Josef, PM Bloomston, JF Botha, ... Journal of the National Comprehensive Cancer Network: JNCCN 7 (4), 350-391, 2009 | 592 | 2009 |
| Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic … TS Hong, JY Wo, BY Yeap, E Ben-Josef, EI McDonnell, LS Blaszkowsky, ... Journal of Clinical Oncology 34 (5), 460-468, 2016 | 472 | 2016 |
| Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer RN Whistance, T Conroy, W Chie, A Costantini, O Sezer, M Koller, ... European journal of cancer 45 (17), 3017-3026, 2009 | 418 | 2009 |
| SWOG S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and … E Ben-Josef, KA Guthrie, AB El-Khoueiry, CL Corless, MM Zalupski, ... Journal of Clinical Oncology 33 (24), 2617-2622, 2015 | 416 | 2015 |
| Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies E Ben-Josef, D Normolle, WD Ensminger, S Walker, D Tatro, ... Journal of Clinical Oncology 23 (34), 8739-8747, 2005 | 402 | 2005 |
| Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines MA Tempero, JP Arnoletti, SW Behrman, E Ben-Josef, AB Benson, ... Journal of the National Comprehensive Cancer Network 10 (6), 703-713, 2012 | 347 | 2012 |
| Pancreatic adenocarcinoma MA Tempero, JP Arnoletti, S Behrman, E Ben-Josef, AB Benson, JD Berlin, ... Journal of the National Comprehensive Cancer Network 8 (9), 972-1017, 2010 | 333 | 2010 |
| Tumor-derived CCL2 mediates resistance to radiotherapy in pancreatic ductal adenocarcinoma A Kalbasi, C Komar, GM Tooker, M Liu, JW Lee, WL Gladney, E Ben-Josef, ... Clinical Cancer Research 23 (1), 137-148, 2017 | 291 | 2017 |
| American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer DA Loblaw, DS Mendelson, JA Talcott, KS Virgo, MR Somerfield, ... Journal of Clinical Oncology 22 (14), 2927-2941, 2004 | 281 | 2004 |
| Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer JD Murphy, S Adusumilli, KA Griffith, ME Ray, MM Zalupski, TS Lawrence, ... International Journal of Radiation Oncology* Biology* Physics 68 (3), 801-808, 2007 | 251 | 2007 |
| Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma FM Barlaskar, AC Spalding, JH Heaton, R Kuick, AC Kim, DG Thomas, ... The Journal of Clinical Endocrinology & Metabolism 94 (1), 204-212, 2009 | 243 | 2009 |
| International patterns of practice in palliative radiotherapy for painful bone metastases: evidence-based practice? A Fairchild, E Barnes, S Ghosh, E Ben-Josef, D Roos, W Hartsell, T Holt, ... International Journal of Radiation Oncology* Biology* Physics 75 (5), 1501-1510, 2009 | 234 | 2009 |
| Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer E Ben-Josef, AF Shields, U Vaishampayan, V Vaitkevicius, BF El-Rayes, ... International Journal of Radiation Oncology* Biology* Physics 59 (2), 454-459, 2004 | 231 | 2004 |
| Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial J Yang, J Wang, H Zhou, Y Zhou, Y Wang, H Jin, Q Lou, X Zhang Endoscopy 50 (08), 751-760, 2018 | 228 | 2018 |
| A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer E Ben-Josef, M Schipper, IR Francis, S Hadley, R Ten-Haken, T Lawrence, ... International Journal of Radiation Oncology* Biology* Physics 84 (5), 1166-1171, 2012 | 218 | 2012 |
| A multi‐institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer EJ Kim, E Ben‐Josef, JM Herman, T Bekaii‐Saab, LA Dawson, KA Griffith, ... Cancer 119 (15), 2692-2700, 2013 | 206 | 2013 |
| Characterization of pancreatic tumor motion using cine MRI: surrogates for tumor position should be used with caution M Feng, JM Balter, D Normolle, S Adusumilli, Y Cao, TL Chenevert, ... International Journal of Radiation Oncology* Biology* Physics 74 (3), 884-891, 2009 | 195 | 2009 |
| Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11 E Ben-Josef, J Moughan, JA Ajani, M Flam, L Gunderson, JD Pollock, ... Journal of clinical oncology 28 (34), 5061-5066, 2010 | 193 | 2010 |
| SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma AB El-Khoueiry, CJ Rankin, E Ben-Josef, HJ Lenz, PJ Gold, RD Hamilton, ... Investigational new drugs 30, 1646-1651, 2012 | 184 | 2012 |
